poisar

Stocks · News reference

EUDA Health Signs MoU With GO POSB Organoids And Shenzhen Innovation Immunotechnology To Collaborate On Therapies Derived From Induced Pluripotent Stem Cells

Jul 28, 2026, 10:12 AMBenzinga Newsdesk

The MOU details the parties intentions to collaborate on the development, manufacturing and commercialization of a first of its kind next generation of off-the-shelf oncology cell therapies for cancer treatment

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

EUDAEUDAW
Source
benzinga
Observed
Jul 28, 2026, 10:12 AM
Checked
Jul 28, 2026, 10:12 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 26, 2026, 10:00 AMEuda Health Holdings Limited

    EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

    EUDA Health Holdings Limited announced that its subsidiary Melana International Pte. Ltd. was recognized as a winner of the SME100 Awards 2026 Singapore. Melana, founded in 2000, manages 31 properties across Singapore with 5,675 residential and commercial units. The award recognizes the company's capabilities in property and strata management and adds to multiple accolades received by Melana in 2026.

    Read original at globenewswire-inc
    EUDAEUDAW